Cargando…
2710. Long Term Use of Contezolid in Lung Transplant Recipients Infected with Nocardia Species
BACKGROUND: Nocardia commonly infects lung transplant recipients (LTR). Current oral options for long-term therapy may result in intolerance or adverse events. Contezolid is a new oxazolidinone antibiotic with potential less toxicity than linezolid that was approved in China. This study describes th...
Autor principal: | Ju, Chunrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678510/ http://dx.doi.org/10.1093/ofid/ofad500.2321 |
Ejemplares similares
-
1700. Efficacy and Safety in Subjects with Renal Impairment in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials
por: Fang, Edward, et al.
Publicado: (2022) -
1118. Population Pharmacokinetics of Contezolid Acefosamil and Contezolid – Rationale for a Safe and Effective Loading Dose Regimen
por: Bulitta, Jürgen B, et al.
Publicado: (2021) -
Contezolid: First Approval
por: Hoy, Sheridan M.
Publicado: (2021) -
1233. Serious Toxicities During Antimicrobial Therapy for Disseminated Nocardia Infection in Solid Organ Transplant Recipients
por: Saling, Christopher, et al.
Publicado: (2021) -
Cutaneous Nocardia arthritidis infection in an orthotopic liver transplant recipient
por: Cheronis, Nicholas, et al.
Publicado: (2019)